Begin main content

Open Calls for Patient Input

This page lists Common Drug Review (CDR) drug applications received by CADTH and the deadlines for filing patient group input for each drug. For more information about how to provide input, please visit the CDR Patient Input page

Kynmobi (apomorphine hydrochloride)

Indications: Parkinson’s Disease

Call For Patient Input: January 25, 2019

Patient Input Closed: March 18, 2019

Crysvita (burosumab )

Indications: Treatment of X-Linked Hypophosphatemia

Call For Patient Input: January 24, 2019

Patient Input Closed: March 15, 2019

Tegsedi (inotersen)

Indications: hereditary transthyretin amyloidosis

Call For Patient Input: January 24, 2019

Patient Input Closed: March 15, 2019

TBC (dolutegravir / lamivudine)

Indications: HIV-1 infection

Call For Patient Input: January 23, 2019

Patient Input Closed: March 14, 2019

TBC (halobetasol propionate and tazarotene)

Indications: Psoriasis, moderate to severe plaque

Call For Patient Input: January 7, 2019

Patient Input Closed: February 26, 2019

Xultophy (insulin degludec + liraglutide)

Indications: Diabetes mellitus, Type 2

Call For Patient Input: January 2, 2019

Patient Input Closed: February 21, 2019